These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12209049)

  • 21. Optimizing care for patients with rheumatic disease worldwide: a concept of global rheumatology.
    Mittleman BB; Lipsky PE
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):575. PubMed ID: 17075591
    [No Abstract]   [Full Text] [Related]  

  • 22. Trials are short, disease long: measuring drug utility beyond clinical trials.
    Luggen ML
    J Rheumatol; 2004 Feb; 31(2):205-6. PubMed ID: 14760785
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic strategies in rheumatology. New concepts, new agents, observance of comorbidities].
    Märker-Hermann E; Gross WL
    Internist (Berl); 2011 Jun; 52(6):643-4. PubMed ID: 21584797
    [No Abstract]   [Full Text] [Related]  

  • 24. The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines.
    Deighton C; Gadsby K
    Musculoskeletal Care; 2006 Sep; 4(3):174-81. PubMed ID: 17042028
    [No Abstract]   [Full Text] [Related]  

  • 25. Change: embrace it or move over.
    Kremer JM
    Curr Opin Rheumatol; 2013 May; 25(3):285-6. PubMed ID: 23492741
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials in pediatric rheumatology: comment on the editorial by Lehman.
    DeWitt EM; Ardoin SP; Rabinovich CE; Schanberg LE
    Arthritis Rheum; 2008 Apr; 58(4):1202-3; author reply 1203. PubMed ID: 18383362
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rheumatology].
    Scherer HU; Burmester GR
    Internist (Berl); 2005 Aug; 46(8):882-91. PubMed ID: 15997385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the efficacy and safety of rheumatic disease treatments: obstacles and proposed solutions.
    Felson DT
    Arthritis Rheum; 2003 Jul; 48(7):1781-7. PubMed ID: 12847670
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials in rheumatology. Does one size fit all?
    Tombetti E; Rovere-Querini P; Manfredi AA
    Rheumatology (Oxford); 2017 May; 56(5):675-676. PubMed ID: 27313279
    [No Abstract]   [Full Text] [Related]  

  • 30. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
    Hill J; Reay N
    Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
    [No Abstract]   [Full Text] [Related]  

  • 31. The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?
    Maini RN
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4():iv106-8. PubMed ID: 16239377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in Pediatric Rheumatology: July 2015-June 2016.
    Sharma A; Vignesh P; Jindal AK; Gupta A
    Int J Rheum Dis; 2017 Apr; 20(4):504-509. PubMed ID: 28205425
    [No Abstract]   [Full Text] [Related]  

  • 33. The prevalence of underpowered randomized clinical trials in rheumatology.
    Keen HI; Pile K; Hill CL
    J Rheumatol; 2005 Nov; 32(11):2083-8. PubMed ID: 16265683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primer: establishing a clinical trial unit - regulations and infrastructure.
    Fleischmann R
    Nat Clin Pract Rheumatol; 2007 Apr; 3(4):234-9. PubMed ID: 17396109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of care in the rheumatic diseases: current status and future directions.
    Yazdany J; MacLean CH
    Curr Opin Rheumatol; 2008 Mar; 20(2):159-66. PubMed ID: 18349745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatologic rehabilitation: the great expectation for rheumatic patients.
    Maddali Bongi S; Matucci Cerinic M
    Reumatismo; 2012 Mar; 64(1):1-6. PubMed ID: 22472777
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease].
    Mariette X
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S8-12. PubMed ID: 16967603
    [No Abstract]   [Full Text] [Related]  

  • 38. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid vasculitis treated with infliximab.
    van der Bijl AE; Allaart CF; Van Vugt J; Van Duinen S; Breedveld FC
    J Rheumatol; 2005 Aug; 32(8):1607-9. PubMed ID: 16078342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sulphasalazine: a promising drug in rheumatology].
    Nasonov EL
    Klin Med (Mosk); 1997; 75(6):39-44. PubMed ID: 9273399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.